BofA raised the firm’s price target on CVS Health (CVS) to $100 from $89 and keeps a Buy rating on the shares following what the firm calls “a mixed-to-good” Q3 report. The firm thinks the initial EPS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results